The FPT Long Châu pharmacy network has officially logged a nationwide operational milestone of 2,678 pharmacies spanning 34 provinces, marking a significant expansion from its baseline of 4 initial stores in Ho Chi Minh City over a 9-year growth trajectory. This infrastructure scaling runs parallel to a corporate strategy establishing localized “healthcare touchpoints” to close medical access disparities, deploying modern residential data architectures, and accelerating global pharmaceutical partnerships to import innovative and orphan drugs into the Vietnamese market.
The documented primary healthcare infrastructure, centralized family data solutions, and innovative medicine procurement strategies feature:
-
Primary Healthcare Network Infrastructure and Delivery Capacity:
-
Touchpoint Distribution: Supplementing its coverage of 2,678 pharmacies across urban, rural, mountainous, and island territories, Long Châu actively operates a parallel network of over 230 vaccination centers nationwide. The consolidated ecosystem delivers continuous healthcare monitoring and services to over 33 million customers (representing approximately one-third of Vietnam’s aggregate population).
-
Workforce Demographics: The organization maintains a professional force of more than 22,000 licensed pharmacists stationed across grassroots medical touchpoints. Dispensing and counseling workflows adhere strictly to the compliance doctrine of “right patient, right prescription, right indication” to solidify long-term therapeutic adherence and scale up public health literacy.
-
-
Integrating Residential Datasets via the “Ví Khỏe Nhà Ta” Digital Solution:
-
Data Interconnection Mechanisms: Long Châu is pioneering the integration of high-security data platforms to roll out the “Ví khỏe nhà ta” (Our Family Health Wallet) feature built upon localized residential databases. Users execute family profile verification (requiring a minimum of 3 household members) by linking directly with the “Resident Information” portal on the national VNeID electronic identification application to activate a unified family account.
-
Cost Optimization and Remote Management: The digital solution enables multi-generational family members to aggregate reward points and combine expenditures across essential healthcare verticals (including prescription medicine, dietary supplements, medical devices, immunizations, and laboratory testing) backed by an introductory voucher suite valued at over 1 million VND. Operationally, the synchronized data interface empowers users to execute remote oversight of chronic disease prescriptions (such as diabetes and hypertension) for elderly relatives or track pediatric immunization schedules within a single application, overriding geographical barriers.
-
-
Global Strategic Alliances and Accelerating Access to Orphan Drugs:
-
Innovative Access Deficits: Citing statistical readouts from healthcare research firm IQVIA MIDAS covering the 2012–2021 historical baseline, out of approximately 460 novel innovative medicines launched globally, patient populations in Vietnam retained access to only 9%, a metric significantly below regional and global standards.
-
Next-Generation Drug Launch Roadmaps: To elevate domestic treatment success rates and mitigate the financial strain of outbound medical tourism, Long Châu is on track to introduce more than 30 next-generation molecules and specialized therapeutic solutions to Vietnam over full-year 2026. Operationalizing this pipeline, the enterprise partnered with a tier-one British pharmaceutical leader in April to launch 3 advanced medical therapeutics targeting high-burden, complex pathologies: severe asthma, systemic lupus erythematosus (SLE), and atypical hemolytic uremic syndrome (aHUS).
-